PD11: Prostate Cancer: Detection & Screening II

Podium Session Moderator(s)

• 

  William Catalona, Dr. (he/him/his)

  Professor of Urology
  Northwestern University Feinberg of Medicine
• 

  J. Stephen Jones, MD

  President & CEO, Inova Health System
  University of Virginia
• 

  Arturo Mendoza-Vald�s, MD

Presentations:

• 1:20 PM – 1:30 PM

  PD11-03: Accuracy and Racial/Ethnic Representation of Prostate Cancer Screening Videos on YouTube and TikTok
  

  Podium Presenter: Max Abramson, BA
• 1:30 PM – 1:40 PM

  PD11-04: The Limited Utility of Prostate Health Index in African American Men with a PSA 4-10
  

  Podium Presenter: Kostantinos Morris, MD
• 1:40 PM – 1:50 PM

  PD11-05: Acquired and Congenital Spinal Cord Injury is Associated with Lower Likelihood of PSA Screening
  

  Podium Presenter: Robert Abouassaly, MD
• 1:50 PM – 2:00 PM

  PD11-06: Baseline PSA below 1.0 ng/ml, and then? Verification of the EAU 2021 Position and Recommendation on risk-adapted early detection using ERSPC Rotterdam data with more than 20 years of detailed follow-up.
  

  Podium Presenter: Renee Hogenhout, MSC – Erasmus MC Cancer Institute
• 2:00 PM – 2:10 PM

  PD11-07: Awareness of risk of prostate cancer (PCa) remains poor in families with germline mutations in DNA-repair genes
  

  Podium Presenter: Giuseppe Chiarelli
• 2:10 PM – 2:20 PM

  PD11-08: A Combined Biomarker/mpMRI Approach Provides Enhanced Clinical Information Prior to Prostate Biopsy
  

  Podium Presenter: Alexander Kretschmer, MD – Klinikum der Universitat Munchen
• 2:20 PM – 2:30 PM

  PD11-09: Perioperative Blood Levels of Prostate-Specific Extracellular Vesicles in Localized Prostate Cancer Treated with Radical Prostatectomy
  

  Podium Presenter: Ali Arafa, MD
• 2:30 PM – 2:40 PM

  PD11-10: Complications after Transperineal Prostate Biopsy without Antibiotic Prophylaxis: a Contribution to the Effort to Control the Spread of Antibiotics Resistance
  

  Podium Presenter: Renee Hogenhout, MSC – Erasmus MC Cancer Institute
• 2:40 PM – 2:50 PM

  PD11-11: A urinary exosome assay interrogating small non-coding RNAs accurately identifies and stratifies prostate cancer into low- intermediate- or high-risk disease.
  

  Podium Presenter: Laurence H. Klotz, MD – Sunnybrook Health Sciences Centre
• 2:50 PM – 3:00 PM

  PD11-12: Associations of Serum-based and Urine-based Molecular Diagnostics with Histologic Subtyping on Prostate Biopsy
  

  Podium Presenter: Claire M. De La Calle, MD – Johns Hopkins Univeristy